| Date Checked | 2026-02-19 22:17:48 |
|---|---|
| Graham Number | (PB)531.75 vs (PE)134.27 |
| Over / Under Value Percentage | 36.06% vs 110.81% |
| Dividend Yield | 0.33% |
| Dividend Date | 2025-12-05 |
| Symbol | REGN |
| AssetType | Common Stock |
| Name | Regeneron Pharmaceuticals Inc |
| Description | Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunology, with leading products like Eylea and Dupixent contributing significantly to its growth. With a robust pipeline of innovative therapies in development, Regeneron is committed to advancing scientific research and addressing critical unmet medical needs, solidifying its influential position within the biopharmaceutical sector. |
| CIK | 872589 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, UNITED STATES, 10591-6707 |
| OfficialSite | https://www.regeneron.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 84896997000 |
| EBITDA | 4348000000 |
| PERatio | 19.2 |
| PEGRatio | 1.601 |
| BookValue | 301.15 |
| DividendPerShare | 2.64 |
| EPS | 41.73 |
| RevenuePerShareTTM | 134.76 |
| ProfitMargin | 0.321 |
| OperatingMarginTTM | 0.296 |
| ReturnOnAssetsTTM | 0.0616 |
| ReturnOnEquityTTM | 0.152 |
| RevenueTTM | 14247800000 |
| GrossProfitTTM | 6530100000 |
| DilutedEPSTTM | 41.73 |
| QuarterlyEarningsGrowthYOY | 0.18 |
| QuarterlyRevenueGrowthYOY | 0.009 |
| AnalystTargetPrice | 821.12 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 15 |
| AnalystRatingHold | 8 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 19.2 |
| ForwardPE | 19.12 |
| PriceToSalesRatioTTM | 5.96 |
| PriceToBookRatio | 2.758 |
| EVToRevenue | 5.59 |
| EVToEBITDA | 13.94 |
| Beta | 0.389 |
| 52WeekHigh | 816.99 |
| 52WeekLow | 475.17 |
| 50DayMovingAverage | 723.52 |
| 200DayMovingAverage | 606.13 |
| SharesOutstanding | 103282000 |
| SharesFloat | 98519000 |
| PercentInsiders | 2.023 |
| PercentInstitutions | 90.411 |
| ExDividendDate | 2025-11-20 |
| dateChecked | 2026-02-19 22:17:48 |
| fresh | 1 |